T3 Pharmaceuticals' Grant

T3 Pharmaceuticals raised a round of funding on February 01, 2018. Investors include BaseLaunch.

T3 Pharmaceuticals focuses on novel therapies for cancer patients. T3 Pharma engineers live bacteria to specifically infect solid tumors and fight them with a proprietary protein delivery technology.…

Articles about T3 Pharmaceuticals' Grant: